Prognostic factors in patients who have survived myocardial infarction

Central European Journal of Medicine

Volumn 5, Issue 4, 2010, Pages 513-519

  Aleksić, Emina D ^a   Stamenković, Radmila Lj ^b   Dordević, Dragan B ^c   Lazarević, Gordana D ^d   Vulić, Duško B ^e   Tasić, Ivan S ^c  

^a Department of Pediatrics Health Care Centre Pirot   (Serbia)

^b Health Care Centre Leskovac   (Serbia)

^c Institute for the Tnerapy and Rehabilitation Ni ka Banja   (Serbia)

^d Clinical Centre Nis   (Serbia)

^e Center for Medical Research   (Bosnia and Herzegovina)

Author keywords

Adverse coronary events; Independent prognostic factors; Myocardial infarction

Indexed keywords

ANTILIPEMIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL;

EID: 77955983263     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-010-0024-7     Document Type: Article

References (32)

1. Bošković D., Vasiljević-Pokrajčić, Acute myocardial infarction, in: Manojloviç D. (editor), Internal Medicine, I edition, Centre for Textbooks and Teaching Resources, Belgrade, 1998, 210-226
2. Murabito J.M., Evans J.C., Larson M.G., Levy D., Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation, Circulation, 1993, 88, 2548-2555
3. Beller G., Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities: The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2001, 103, 2428-2435
4. Thom T.J., Kannel W.B., Silbershatz H., D'Agostino R.B., Cardiovascular disease in the United States and preventive approaches. In: Fuster V., Alexander R.W., O'Rourke R.A. (Eds.), Hurst's The Heart, Arteries and Veins, 10th ed., New York, NY: McGraw- Hill, 2001
5. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al., European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and the Other Societies on Cardiovascular Disease Prevention in Clinical Practice, Eur. Heart J., 2007, 1-40
6. Gerber Y., Jacobsen S.J., Frye R.L., Weston S.A., Killian J.M., Roger V.L., Secular Trends in Deaths From Cardiovascular Diseases A 25-Year Community Study, Circulation, 2006, 113, 2285-2292
7. McGovern P.G., Jacobs D.R. Jr, Shahar E., ArnettD.K., Folsom A.R., Blackburn H., et al., Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota Heart Survey, Circulation, 2001, 104, 19-24
8. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H., Coronary heart disease trends in four United States communities: the Atherosclerosis Risk in Communities (ARIC) study 1987-1996., Int. J. Epidemiol. 2001, 30, Suppl 1, S17-S22
9. Fox C.S., Evans J.C., Larson M.G., Kannel W.B., Levy D., Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study, Circulation, 2004, 110, 522-527
10. Goraya T.Y., Jacobsen S.J., Kottke T.E., Frye R.L., Weston S.A., Roger V.L., Coronary heart disease death and sudden cardiac death: a 20-year population-based study, Am. J. Epidemiol., 2003, 157, 763-770
11. Salomaa V., Ketonen M., Koukkunen H., Immonen- Raiha P., Jerkkola T., Karja-Koskenkari P., et al., Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI Study, Circulation, 2003, 108, 691-696
12. Derby C.A., Lapane K.L., Feldman H.A., Carleton R.A., Sex-specific trends in validated coronary heart disease rates in southeastern New England, 1980-1991., Am. J. Epidemiol., 2000, 151, 417-429
13. Roger V.L., Jacobsen S.J., Weston S.A., Bailey K.R., Kottke T.E., Frye R.L., Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994., Mayo Clin. Proc., 1999, 74, 651-657
14. Køber L., Torp-Pedersen C., Otteses M., Burchardt H., Korup E., Lyngborg K., Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute MI. TRACE study group, Am. J. Cardiol., 1996, 78, 158-162
15. Køber L., Torp-Pedersen C., Ottesen M., Rasmussen S., Lessing M., Skagen K., and The TRACE study group, Influence of gender on short- and long-term mortality after acute myocardial infarction, Am. J. Cardiol., 1996, 77, 1052-1056
16. Alagona P., Beyond LDL Cholesterol: The Role of Elevated Triglycerides and Low HDL Cholesterol in Residual CVD Risk Remaining After Statin Therapy, Am. J. Manag. Care, 2009, 15, S65-S73
17. Fruchart J.C., Sacks F., Hermans M.P., Assmann G., Brown W., Ceska R., et al., The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia, Am. J. Cardiol., 2008, 102, Suppl 1, 1K-34K
18. Manocha A., Srivastava LM., Triglycerides as independent risk factor in coronary heart disease: emerging trends in the post prandial state, J. Med. Sci., 2002, 5, 7-16
19. VulićD., Measures of Secondary Prevention of Coronary Disease, Balneoclimatologia, 2007, 31, 42-62
20. Miller M., Cannon C.P., Murphy S.A., Qin J., Ray K.K., Braunwald E., Impact of triglyceride levels beyond lowdensity lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial, J. Am. Coll. Cardiol., 2008, 51, 724-730
21. Genest J.J. Jr, Martin-Munley S.S., McNamara J.R., Ordovas J.M., Jenner J., Myers R.H., et al., Familial lipoprotein disorders in patients with premature coronary artery disease, Circulation, 1992, 85, 2025-2033
22. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., et al., Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial, JAMA, 2001, 285, 1711-1718
23. Rasmussen J.N., Chong A., Alter D.A., Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction, JAMA, 2007, 297, 177-186
24. Kanadaşi M., Cayli M., Demirtaş M., Inal T., Demir M., Koç M., et al., The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol, Heart Vessels, 2006, 21, 291-297
25. Athyros V.G., Papageorgiou A.A., Mercouris B.R., Athyrou V.V., Symeonidis A.N., Basayannis E.O., et al., Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronaryheart- disease Evaluation (GREACE) study, Curr. Med. Res. Opin. 2002, 18, 4, 220-228
26. Fletcher G.F., Balady G.J., Blair S.N., Blumenthal J., Caspersen C., Chaitman B., et al., Statement on exercise: benefits and recommendations for physical activity programs for all Americans, Circulation, 1996, 94, 857-862
27. O'Connor G.T., Buring J.E., Yusuf S., Goldhaber S.Z., Olmstead E.M., Paffenbarger R.S., et al., An overview of randomized trials of rehabilitation withexercice after myocardial infarction, Circulation, 1989, 80, 234-244
28. Kosteva K., Wood D.A., De Bacquer D., Heidrich J., De Backer G, on behalf of the EUROASPIRE II Study Group, Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from EUROSPIRE II survey, Eur. Heart J. Suppl., 2004, 6, Suppl J, J17-J26
29. Witt B. J., Jacobsen S.J., Weston S.A., Killian J. M., Meverden R. A., Allison T., et al., Cardiac rehabilitation after myocardial infarction in the community, J. Am. Coll. Cardiol., 2004, 44, 988-996
30. Taylor R.S., Brown A., Ebrahim S., Jolliffe J., Noorani H., Rees K., et al., Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials. Am. J. Med., 2004, 116, 682-692
31. Unal B., Critchley J.A., Capewell S., Explaining the decline in coronary heart disease mortality in England and Wales between 1981. and 2000., Circulation, 2004, 109, 1101-1107
32. Murchie P., Campbell N.C., Ritchie L.D., Simpson J.A., Thain J., Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care, BMJ, 2003, 326, 84